| Ident. | Authors (with country if any) | Title |
|---|
| 000019 |
Y J Liu [République populaire de Chine] ; Y L Yang [République populaire de Chine] ; Y. Xu [République populaire de Chine] | [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019]. |
| 000108 |
David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000116 |
| The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 |
| 000124 |
Shajeea Arshad Ali ; Mariam Baloch ; Naseem Ahmed ; Asadullah Arshad Ali ; Ayman Iqbal | The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat |
| 000188 |
Jiabao Xu ; Shizhe Zhao ; Tieshan Teng ; Abualgasim Elgaili Abdalla ; Wan Zhu ; Longxiang Xie ; Yunlong Wang [République populaire de Chine] ; Xiangqian Guo | Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV |
| 000232 |
Chih-Cheng Lai [Taïwan] ; Tzu-Ping Shih [Taïwan] ; Wen-Chien Ko [Taïwan] ; Hung-Jen Tang [Taïwan] ; Po-Ren Hsueh [Taïwan] | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges |
| 000245 |
Anu Haveri [Finlande] ; Teemu Smura [Finlande] ; Suvi Kuivanen [Finlande] ; Pamela Österlund [Finlande] ; Jussi Hepojoki [Suisse] ; Niina Ikonen [Finlande] ; Marjaana Pitk Paasi [Finlande] ; Soile Blomqvist [Finlande] ; Esa Rönkkö [Finlande] ; Anu Kantele [Finlande] ; Tomas Strandin [Finlande] ; Hannimari Kallio-Kokko [Finlande] ; Laura Mannonen [Finlande] ; Maija Lappalainen [Finlande] ; Markku Broas [Finlande] ; Miao Jiang [Finlande] ; Lotta Siira [Finlande] ; Mika Salminen [Finlande] ; Taneli Puumalainen [Finlande] ; Jussi Sane [Finlande] ; Merit Melin [Finlande] ; Olli Vapalahti [Finlande] ; Carita Savolainen-Kopra [Finlande] | Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. |
| 000289 |
Alexander J. Keeley [Royaume-Uni] ; Cariad Evans [Royaume-Uni] ; Hayley Colton [Royaume-Uni] ; Michael Ankcorn [Royaume-Uni] ; Alison Cope [Royaume-Uni] ; Amy State [Royaume-Uni] ; Tracy Bennett [Royaume-Uni] ; Prosenjit Giri [Royaume-Uni] ; Thushan I. De Silva [Royaume-Uni] ; Mohammad Raza [Royaume-Uni] | Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020. |
| 000303 |
Lisa E. Gralinski ; Vineet D. Menachery [États-Unis] | Return of the Coronavirus: 2019-nCoV |
| 000333 |
Pete Kinross [Suède] ; Carl Suetens [Suède] ; Joana Gomes Dias [Suède] ; Leonidas Alexakis [Suède] ; Ariana Wijermans [Suède] ; Edoardo Colzani [Suède] ; Dominique L. Monnet [Suède] ; European Centre For Disease Prevention And Control Ecdc Public Health Emergency Team | Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020. |
| 000371 |
Sai Krishna Gudi [Canada] ; Komal Krishna Tiwari [Canada] | Preparedness and Lessons Learned from the Novel Coronavirus Disease. |
| 000429 |
Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine] | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. |
| 000434 |
Henrik Sjödin [Suède] ; Annelies Wilder-Smith [Allemagne] ; Sarah Osman [Suède] ; Zia Farooq [Suède] ; Joacim Rocklöv [Suède] | Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020. |
| 000543 |
Kristin Tolksdorf [Allemagne] ; Silke Buda [Allemagne] ; Ekkehard Schuler [Allemagne] ; Lothar H. Wieler [Allemagne] ; Walter Haas [Allemagne] | Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19). |
| 000602 |
Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon] | Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. |
| 000825 |
Xiao-Wei Xu [République populaire de Chine] ; Xiao-Xin Wu [République populaire de Chine] ; Xian-Gao Jiang [République populaire de Chine] ; Kai-Jin Xu [République populaire de Chine] ; Ling-Jun Ying [République populaire de Chine] ; Chun-Lian Ma [République populaire de Chine] ; Shi-Bo Li [République populaire de Chine] ; Hua-Ying Wang [République populaire de Chine] ; Sheng Zhang [République populaire de Chine] ; Hai-Nv Gao [République populaire de Chine] ; Ji-Fang Sheng [République populaire de Chine] ; Hong-Liu Cai [République populaire de Chine] ; Yun-Qing Qiu [République populaire de Chine] ; Lan-Juan Li [République populaire de Chine] | Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. |
| 000993 |
Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine] | Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |
| 000A29 |
Fan Wu [République populaire de Chine] ; Su Zhao [République populaire de Chine] ; Bin Yu [République populaire de Chine] ; Yan-Mei Chen [République populaire de Chine] ; Wen Wang [République populaire de Chine] ; Zhi-Gang Song [République populaire de Chine] ; Yi Hu [République populaire de Chine] ; Zhao-Wu Tao [République populaire de Chine] ; Jun-Hua Tian [République populaire de Chine] ; Yuan-Yuan Pei [République populaire de Chine] ; Ming-Li Yuan [République populaire de Chine] ; Yu-Ling Zhang [République populaire de Chine] ; Fa-Hui Dai [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Qi-Min Wang [République populaire de Chine] ; Jiao-Jiao Zheng [République populaire de Chine] ; Lin Xu [République populaire de Chine] ; Edward C. Holmes [République populaire de Chine] ; Yong-Zhen Zhang [République populaire de Chine] | A new coronavirus associated with human respiratory disease in China. |
| 000A77 |
Xin Chen [Taïwan] ; Chi-Yuan Chou ; Gu-Gang Chang | Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme. |
| 000A79 |
Lilin Zhong [États-Unis] ; Lia Haynes ; Evi Budo Struble ; Azaibi Tamin ; Maria Luisa Virata-Theimer ; Pei Zhang | Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein. |
| 000A98 |
Paul K. S. Chan [République populaire de Chine, Hong Kong] ; W. K. To [République populaire de Chine] ; Esther Y. M. Liu [République populaire de Chine] ; T. K. Ng [République populaire de Chine] ; John S. Tam [République populaire de Chine] ; Joseph J. Y. Sung [République populaire de Chine] ; Jean-Michel Lacroix [Canada] ; Michel Houde [Canada] | Evaluation of a peptide‐based enzyme immunoassay for anti‐SARS coronavirus IgG antibody |
| 000B03 |
Ali A. Rabaan [Arabie saoudite] ; Shamsah H. Al-Ahmed [Arabie saoudite] ; Shafiul Haque [Arabie saoudite] ; Ranjit Sah [Népal] ; Ruchi Tiwari [Inde] ; Yashpal Singh Malik [Inde] ; Kuldeep Dhama [Inde] ; M Iqbal Yatoo [Inde] ; D Katterine Bonilla-Aldana ; Alfonso J. Rodriguez-Morales [Colombie] | SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview |
| 000B17 |
Carlyn Harris [États-Unis, Royaume-Uni] ; Gail Carson [Royaume-Uni] ; J Kenneth Baillie [Royaume-Uni] ; Peter Horby [Royaume-Uni] ; Harish Nair [Royaume-Uni] | An evidence-based framework for priority clinical research questions for COVID-19 |
